A carregar...
Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers
BACKGROUND: Hospitals in the Middle East Gulf region have experienced an influx of COVID-19 patients to their medical wards and intensive care units. The hypercoagulability of these patients has been widely reported on a global scale. However, many of the experimental treatments used to manage the v...
Na minha lista:
| Publicado no: | Thromb J |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7479301/ https://ncbi.nlm.nih.gov/pubmed/32922212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-020-00236-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|